Detalhe da pesquisa
1.
Reducing Unnecessary Prostate Multiparametric Magnetic Resonance Imaging by Using Clinical Parameters to Predict Negative and Indeterminate Findings.
J Urol
; 203(2): 292-298, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31479397
2.
Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
J Urol
; 204(6): 1187-1194, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496160
3.
Using decision curve analysis to benchmark performance of a magnetic resonance imaging-based deep learning model for prostate cancer risk assessment.
Eur Radiol
; 30(12): 6867-6876, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591889